Androgen deprivation therapy

Aliases
ADT, Chemotherapy-Hormones/Steroids, endocrine therapy, Endocrine Therapy, Hormonal Therapy (3 other aliases)

19 clinical trials

33 products

17 abstracts

12 indications

5 targets

Indication
Prostate Cancer
Indication
Antiandrogens
Indication
Prostate cancer
Clinical trial
Fluzoparib and Abiraterone in the preSurgery Treatment of Prostate Cancer: FAST Trial
Status: Active (not recruiting), Estimated PCD: 2023-12-01
Abstract
The effect of maintenance hormone therapy on overall survival in advanced-stage low-grade serous ovarian carcinoma: A risk-set matched retrospective study.
Org: Massachusetts General Hospital, Meigs Division of Gynecologic Oncology, Vincent Department of Obstetrics & Gynecology, University of Texas MD Anderson Cancer Center,
Abstract
Treatment outcomes in patients with discordant recurrence score and RSClin risk predictions.
Org: University of Chicago, University of Chicago Medical Center, Chicago, IL, University of Chicago Department of Public Health Sciences, Center for Data Intensive Science at the University of Chicago, Department of Medicine, University of Chicago,
Abstract
Clinical outcomes of immune checkpoint inhibitor treatment in patients with classic cold tumors identified to have a high tumor mutational burden via ctDNA.
Org: Guardant Health, Inc., Mayo Clinic Florida, Mayo Clinic, Emory University, Atlanta, GA, USA, Miami Cancer Institute - Baptist Health South Florida,
Abstract
Androgen-deprivation therapy and risk of dementia in patients with prostate cancer: Clinical outcomes from real-world data.
Org: MetroHealth Medical Center, Case Western Reserve University School of Medicine, Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Seidman Cancer Center, Johns Hopkins University - School of Medicine,
Abstract
Nutrition assessment reports in oncology clinical trials.
Org: Department of Supportive Oncology, Levine Cancer Institute, Atrium Health Carolinas Medical Center, Department of Internal Medicine at Atrium Health Carolinas Medical Center, Department of Solid Tumor Oncology and Supportive Oncology,
Abstract
Crossing the US-Mexico border for cancer care: Which treatments are more sought-after?
Org: Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, University of North Carolina at Chapel Hill, Vanderbilt University Medical Center, ISSSTE CMN 20 De Noviembre, Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, Mexico,
Abstract
An analysis of National Cancer Data Base: Male breast cancer and overall survival.
Org: Creighton University Medical Center, Creighton University School of Medicine Phoenix Regional Campus, Department of Hematology Oncology, Kaiser Permanente, University of Nebraska Medical Center, Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University,
Abstract
Impact of COVID-19 pandemic on the treatment of prostate cancer in the Brazilian Public Health System.
Org: LACOG - Latin American Cooperative Oncology Group, University of California, San Diego (UCSD), University of California at San Diego, Univeristy of California San Diego, Hospital Beneficência Portuguesa de São Paulo, São Paulo, Brazil,
Abstract
The impact of the COVID-19 pandemic on the diagnosis and treatment of breast cancer at a community hospital.
Org: Gundersen Health System, La Crosse, WI, Gundersen Medical Center,
Abstract
Neoadjuvant therapy (NAT) in early breast cancer (EBC): Results from a prospective observational multicenter BRIDE study.
Org: Oncologia Medica - IRCCS Ospedale Sacro Cuore Don Calabria, Negrar Di Valpolicella (VR), Italy, IRCCS Regina Elena National Cancer Institute, Division of Medical Oncology 1, Rome, Italy, Roma, Italy, Oncologia - Humanitas Gavazzeni, Bergamo, Italy, Oncologia - Azienda Sanitaria dell’Alto Adige, Bolzano, Italy,
Product
SBRT + ADT
Product
ADT+ARPI